Abrdn Healthcare Investors (NYSE:HQH) Shares Purchased by Comerica Bank

Comerica Bank increased its holdings in shares of Abrdn Healthcare Investors (NYSE:HQH) by 17.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 7,504 shares of the financial services provider’s stock after purchasing an additional 1,105 shares during the period. Comerica Bank’s holdings in Abrdn Healthcare Investors were worth $120,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of HQH. Millstone Evans Group LLC bought a new stake in Abrdn Healthcare Investors in the fourth quarter valued at about $29,000. Brown Brothers Harriman & Co. acquired a new position in Abrdn Healthcare Investors during the 4th quarter valued at about $48,000. Wealthfront Advisers LLC acquired a new position in shares of Abrdn Healthcare Investors during the 4th quarter valued at $118,000. Stratos Wealth Partners LTD. acquired a new stake in Abrdn Healthcare Investors in the 4th quarter valued at about $187,000. Finally, Stifel Financial Corp increased its holdings in shares of Abrdn Healthcare Investors by 38.7% in the fourth quarter. Stifel Financial Corp now owns 13,975 shares of the financial services provider’s stock valued at $224,000 after buying an additional 3,900 shares in the last quarter. 32.60% of the stock is currently owned by hedge funds and other institutional investors.

Abrdn Healthcare Investors Stock Up 1.7%

Shares of Abrdn Healthcare Investors stock opened at $15.72 on Monday. Abrdn Healthcare Investors has a 12 month low of $13.77 and a 12 month high of $19.79. The business has a fifty day simple moving average of $15.72 and a 200-day simple moving average of $16.78.

Abrdn Healthcare Investors Company Profile

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.